U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H25N8O11S2.Na
Molecular Weight 712.643
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of CEFTOBIPROLE MEDOCARIL

SMILES

[Na+].[H][C@]12SCC(\C=C3/CCN([C@@H]4CCN(C4)C(=O)OCC5=C(C)OC(=O)O5)C3=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C6=NSC(N)=N6)C([O-])=O

InChI

InChIKey=MFAWUGGPPMTWPU-LCJFHXTKSA-M
InChI=1S/C26H26N8O11S2.Na/c1-10-14(45-26(41)44-10)8-43-25(40)32-4-3-13(7-32)33-5-2-11(20(33)36)6-12-9-46-22-16(21(37)34(22)17(12)23(38)39)28-19(35)15(30-42)18-29-24(27)47-31-18;/h6,13,16,22,42H,2-5,7-9H2,1H3,(H,28,35)(H,38,39)(H2,27,29,31);/q;+1/p-1/b11-6+,30-15-;/t13-,16-,22-;/m1./s1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C26H25N8O11S2
Molecular Weight 689.654
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 2
Optical Activity UNSPECIFIED

Ceftobiprole is a fifth-generation cephalosporin antibiotic. It was discovered by Basilea Pharmaceutica and was developed by Johnson & Johnson Pharmaceutical Research and Development. The drug is demonstrates activity against clinically important gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, penicilliin-resistant Staphylococcus pneumoniae, and Enterococcus faecalis. The drug also has demonstrated activity against gram-negative bacteria including Citrobacter spp., Escherichia coli, Enterobacter spp., Klebsiella spp., Serratia marcescens, and Pseudomonas aeruginosa. The drug has gained regulatory authorization from European states for the treatment of hospital-acquired pneumonia (HAP, excluding ventilator-associated pneumonia, VAP) and community-acquired pneumonia (CAP).

Approval Year

Targets

Targets

PubMed

PubMed

TitleDatePubMed
Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees.
2007 Dec
Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.
2007 Jul
Clinical profile of ceftobiprole, a novel beta-lactam antibiotic.
2007 Jun
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
2008 Jan
In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
2008 Oct
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:41:24 GMT 2023
Edited
by admin
on Fri Dec 15 15:41:24 GMT 2023
Record UNII
N99027V28J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CEFTOBIPROLE MEDOCARIL
DASH   EMA EPAR   MART.   USAN  
USAN  
Official Name English
Ceftobiprole medocaril sodium [WHO-DD]
Common Name English
BAL5788
Code English
RO-65-5788
Code English
CEFTOBIPROLE MEDOCARIL [MART.]
Common Name English
CEFTOBIPROLE MEDOCARIL SODIUM SALT
MI  
Common Name English
CEFTOBIPROLE MEDOCARIL [USAN]
Common Name English
CEFTOBIPROLE MEDOCARIL SODIUM SALT [MI]
Common Name English
RO 65-5788
Code English
BAL-5788
Code English
BAL5788-001
Code English
BAL-5788-001
Code English
CEFTOBIPROLE MEDOCARIL SODIUM
WHO-DD  
Common Name English
CEFTOBIPROLE MEDOCARIL [EMA EPAR]
Common Name English
RO-655788
Code English
Classification Tree Code System Code
WHO-ATC J01DI01
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
WHO-VATC QJ01DI01
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
NCI_THESAURUS C357
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
EMA ASSESSMENT REPORTS ZEFTERA (REFUSED SOFT TISSUE INFECTIONS)
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
Code System Code Type Description
DRUG BANK
DB14733
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
EVMPD
SUB130376
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
USAN
SS-13
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
CAS
252188-71-9
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
SMS_ID
100000156073
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
EPA CompTox
DTXSID601021562
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
FDA UNII
N99027V28J
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
DRUG CENTRAL
4402
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
ChEMBL
CHEMBL1652606
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
MERCK INDEX
m3223
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C70597
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
PUBCHEM
135413543
Created by admin on Fri Dec 15 15:41:24 GMT 2023 , Edited by admin on Fri Dec 15 15:41:24 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY